Concepedia

Author

Xueting Yao

Peking University Third HospitalORCID

Also Known As

X.-L. Yao, Xueting Yao

48

Publications

3.2K

Citations

11

H-Index

17

Concepts

All Affiliations

Peking University Third HospitalPeking UniversityPeking Union Medical College HospitalChinese Academy of Medical Sciences & Peking Union Medical CollegeFudan University
XY

About

Xueting Yao is an author at Peking University Third Hospital specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

41

2

Pharmacology

2

2

41

3

Engineering

1

1

15

4

Immunology

1

1

26

5

Rheumatology

1

1

26

Xueting Yao

×

11

Publications

3K

Citations

10

H-Index

YearCitations

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Xueting Yao, Fei Ye, Miao Zhang,

Clinical Infectious Diseases

2020

2.8K

Dose selection of chloroquine phosphate for treatment of COVID-19 based on a physiologically based pharmacokinetic model

Cheng Cui, Miao Zhang, Xueting Yao,

Acta Pharmaceutica Sinica B

2020

50

Cytotoxicity Evaluation of Chloroquine and Hydroxychloroquine in Multiple Cell Lines and Tissues by Dynamic Imaging System and Physiologically Based Pharmacokinetic Model

Jianling Yang, Zhengyang Guo, Xu Liu,

Frontiers in Pharmacology

2020

33

Development of a physiologically based pharmacokinetic (PBPK) population model for Chinese elderly subjects

Cheng Cui, Jie En Valerie Sia, Siqi Tu,

British Journal of Clinical Pharmacology

2020

32

Comprehensive PBPK model to predict drug interaction potential of Zanubrutinib as a victim or perpetrator

Kun Wang, Xueting Yao, Miao Zhang,

CPT Pharmacometrics & Systems Pharmacology

2021

28

Pharmacokinetics analysis based on target-mediated drug distribution for RC18, a novel BLyS/APRIL fusion protein to treat systemic lupus erythematosus and rheumatoid arthritis

Xueting Yao, Yupeng Ren, Qian Zhao,

European Journal of Pharmaceutical Sciences

2021

26

Translational prediction of first-in-human pharmacokinetics and pharmacodynamics of janagliflozin, a selective SGLT2 inhibitor, using allometric scaling, dedrick and PK/PD modeling methods

Ling Song, Xueting Yao, Yang Liu,

European Journal of Pharmaceutical Sciences

2020

15

A high‐performance liquid chromatography–tandem mass spectrometry method for simultaneous determination of imigliptin, its five metabolites and alogliptin in human plasma and urine and its application to a multiple‐dose pharmacokinetic study

Yang Liu, Ling Song, Xueting Yao,

Biomedical Chromatography

2018

14

Development of a Physiologically Based Pharmacokinetic Model for Hydroxychloroquine and Its Application in Dose Optimization in Specific COVID-19 Patients

Miao Zhang, Xueting Yao, Zhe Hou,

Frontiers in Pharmacology

2021

12

Safety, tolerability, pharmacokinetics, and pharmacodynamics of the glucokinase activator PB-201 and its effects on the glucose excursion profile in drug-naïve Chinese patients with type 2 diabetes: a randomised controlled, crossover, single-centre phase 1 trial

Dongyang Liu, Ying Du, Xueting Yao,

EClinicalMedicine

2021

11

Page 1